I. M. Kolmogorov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
I. M. Kolmogorov has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Irina M. Le-Deygen
Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia
2 shared publications - A. I. Gayda
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health
1 shared publication A.A. Yaroslavov
1 shared publicationA.M. Adelyanov
1 shared publication- Anastasiya G. Samoylova
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Ministry of Health of the Russian Federation
1 shared publication - Andrej A. Anosov
Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication
Latest Publications
- 14 May 2026
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (2)
Linezolid Delivery Methods to the Site of Tuberculosis Inflammation: a Systematic Review
50 scientific publications between 2018 and 2025 were analyzed, focusing on drug delivery systems and benefits of linezolid-loaded nanoparticles. Orally administered anti-tuberculosis drugs do not always achieve sufficient bactericidal concentrations at the site of infection, regardless of their serum levels. Consequently, even with treatment adherence, approximately 1% of patients may develop multidrug-resistant tuberculosis (MDR-TB) due to pharmacokinetic variability. This highlights the need for advanced delivery systems that ensure targeted drug release directly into the affected lung tissue. Nanoformulations of linezolid (e.g., dry powders, aerosols) have been developed. These formulations remain stable for up to 6 months and increase bioavailability to 55.2%, enabling dose reduction. This opens up real prospects for lowering the therapeutic dose of the drug.
- 14 May 2026
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (2)
Linezolid Delivery Methods to the Site of Tuberculosis Inflammation: a Systematic Review
50 scientific publications between 2018 and 2025 were analyzed, focusing on drug delivery systems and benefits of linezolid-loaded nanoparticles. Orally administered anti-tuberculosis drugs do not always achieve sufficient bactericidal concentrations at the site of infection, regardless of their serum levels. Consequently, even with treatment adherence, approximately 1% of patients may develop multidrug-resistant tuberculosis (MDR-TB) due to pharmacokinetic variability. This highlights the need for advanced delivery systems that ensure targeted drug release directly into the affected lung tissue. Nanoformulations of linezolid (e.g., dry powders, aerosols) have been developed. These formulations remain stable for up to 6 months and increase bioavailability to 55.2%, enabling dose reduction. This opens up real prospects for lowering the therapeutic dose of the drug.
- 1 November 2025
- Published by Kotelnikov Institute of Radioengineering and Electronics of Russian Academy of Sciences in Journal of Radio Electronics
- Vol. 2025 (11)
Interaction of magnetite nanoparticles with a bilayer lipid membrane
This study investigates the mechanisms of interaction between superparamagnetic magnetite nanoparticles (MNPs) and a lipid bilayer membrane (BLM). Ligand-free polar magnetite nanoparticles, which form a colloidal suspension in the aqueous phase, can penetrate the BLM without compromising its integrity. As magnetite MNPs pass through the membrane, complexes of the nanoparticles with lipid molecules are formed, which are detected in the aqueous phase behind the membrane. In this study, independent experimental methods of structure-functional diagnostics, including FTIR spectroscopy, dynamic light scattering, scanning transmission electron microscopy (STEM), and energy-dispersive X-ray (EDX) spectroscopy, were used to characterize nanocomposite complexes adsorbed on novel magnetic traps installed behind a planar azolectin BLM. The obtained results indicate that the resulting complexes are polydisperse with characteristic sizes in the range of 10–300 nm and have an iron-containing core surrounded by a lipid shell in the form of bilayers or multilayers of lipid molecules. Using the Langmuir-Blodgett method, the interaction of colloidal magnetite MNPs in the aqueous phase with lipid azolectin monolayers on the surface of the aqueous subphase in an external nonuniform magnetic field was studied. The corresponding monolayer Langmuir films, deposited on a solid mica substrate using the Schaeffer and Langmuir-Blodgett methods, were studied by atomic force microscopy (AFM) in tapping mode. The results of a topographic analysis of the structure of the obtained nanocomposite Langmuir films containing complexes of magnetite nanoparticles and azolectin molecules are consistent with the above-mentioned structural analysis of nanocomposite complexes formed during the interaction of magnetite nanoparticles with a bilayer lipid membrane.
- 1 November 2025
- Published by Kotelnikov Institute of Radioengineering and Electronics of Russian Academy of Sciences in Journal of Radio Electronics
- Vol. 2025 (11)
Interaction of magnetite nanoparticles with a bilayer lipid membrane
This study investigates the mechanisms of interaction between superparamagnetic magnetite nanoparticles (MNPs) and a lipid bilayer membrane (BLM). Ligand-free polar magnetite nanoparticles, which form a colloidal suspension in the aqueous phase, can penetrate the BLM without compromising its integrity. As magnetite MNPs pass through the membrane, complexes of the nanoparticles with lipid molecules are formed, which are detected in the aqueous phase behind the membrane. In this study, independent experimental methods of structure-functional diagnostics, including FTIR spectroscopy, dynamic light scattering, scanning transmission electron microscopy (STEM), and energy-dispersive X-ray (EDX) spectroscopy, were used to characterize nanocomposite complexes adsorbed on novel magnetic traps installed behind a planar azolectin BLM. The obtained results indicate that the resulting complexes are polydisperse with characteristic sizes in the range of 10–300 nm and have an iron-containing core surrounded by a lipid shell in the form of bilayers or multilayers of lipid molecules. Using the Langmuir-Blodgett method, the interaction of colloidal magnetite MNPs in the aqueous phase with lipid azolectin monolayers on the surface of the aqueous subphase in an external nonuniform magnetic field was studied. The corresponding monolayer Langmuir films, deposited on a solid mica substrate using the Schaeffer and Langmuir-Blodgett methods, were studied by atomic force microscopy (AFM) in tapping mode. The results of a topographic analysis of the structure of the obtained nanocomposite Langmuir films containing complexes of magnetite nanoparticles and azolectin molecules are consistent with the above-mentioned structural analysis of nanocomposite complexes formed during the interaction of magnetite nanoparticles with a bilayer lipid membrane.